At we run an actively managed online portfolio of the “best ideas” from the world’s best billionaire investors and hedge funds. With that, we pay close attention anytime one of these great investors is making the case for one of their positions, particularly when feel confident enough to call it one of their best ideas. That’s precisely what we got a glimpse of these past two days at an annual fund raising event, the Robin Hood Investment Conference, hosted by billionaire hedge funder Paul Tudor Jones.

Here is a quick recap of their best ideas:

1) David Tepper- Billionaire David Tepper called the Chinese currency extremely overvalued. This view is in line with one he expressed in the past few weeks, arguing for the potential for China’s central bank to ease monetary policy more aggressively than most have thought. An aggressively easing PBOC and weakening of the yuan would be needed fuel for the sluggish Chinese economy, which would bode well for the outlook for Chinese stocks.

2) T. Boone Pickens – Self-made billionaire Boone Pickens told the Robin Hood audience to expect $70 oil by June of next year, which would be almost a double from oil’s price today. Pickens also said he liked the oil stock Pioneer Natural Resources (PXD). To trade Boone Pickens oil call you can buy the oil ETF (USO) or the oil and gas producers ETF (XOP).

3) Bill Ackman- Ackman reiterated his belief that Valeant (VRX) was extremely undervalued and that it should merge with Allergan (AGN) ,because Ackman does not believe the Allergan-Pfizer merger would be approved. Ackman also reiterated his view that Herbalife (HLF) was still a compelling short, with news from the DOJ to possibly come out today on nutritional supplements.

4) Larry Robbins – Billionaire Larry Robbins founder of the hedge fund Glenview Capital, pitched FMC, HCA and MON. Monsanto is Robbin’s second biggest position in his fund at almost $1.2 billion.

5) Dan Loeb – Billionaire Dan Loeb of Third Point said he thought Amgen (AMGN) and Allergan (AGN) should merge. Amgen is Loeb’s second biggest position in his hedge fund, at almost 13% or $1.4 billion.

6) John Paulson – Billionaire John Paulson’s top associate Samantha Greenberg pitched Charter Communications (CHTR). Greenberg said that Charter could be worth as much as $294 over the next year or almost a 60% return
from its share price today.

7) David Einhorn – Billionaire David Einhorn pitched Consol Energy (CNX). Einhorn first took a position in Consol at around $37 last year, today it sells for $7.80. That means if Consol just went back to the price Billionaire David Einhorn paid that would be more than a 350% return.

To see which ideas we follow in our Billionaire’s Portfolio, join us at

Related: Stocks, Stock Market, Economy, Billionaires, Trump, Markets, Investing, Finance, Commodities


Billionaire investor, Bill Ackman, CEO of Pershing Square Capital Management, has one of the best investing track records in the world.
When you add back fees, Ackman has returned 1,199% since starting his fund in 2004. That compares to 119% in the S&P 500 for the same period. That’s ten times better than the S&P 500.

His short position on Herbalife has been very well documented. In his interview with Bloomberg on Thursday, he said “it will” go to zero, and he confidently said his fund is “very short.” This comes after the stock has halved since July of last year.

A billionaire face-off on Herbalife started early 2013, following a presentation by Ackman at the Ira Sohn investment conference in New York, where he made the case for his Herbalife short. It included the accusation that Herbalife was running a ponzi-scheme. At that time, the stock was trading the mid $30s. Months later, billionaires Dan Loeb and Carl Icahn both took shots at Ackman’s thesis, and took long positions in the stock, attempting to squeeze Ackman. It worked, for a while. The stock ultimately ran up to $81 in January of 2014.

Ackman says they “bought a lot of put options” on that run up, “in the $70s and $80s.” Now HLF shares are trading back in the $30s, and Ackman says it’s a race to the bottom. He thinks the stock will either hit zero or the government will step in before that, and shut them down.

At this point, Ackman’s campaign against Herbalife is looking quite good.

Love him or hate him, Ackman is one of the best performing investors on the planet, and for average investors, his portfolio might be one of the easiest to replicate. We know about his Herbalife position. Here’s a look at the seven publicly reported core holdings of Ackman’s $18+ billion Pershing Square fund, as of its recent SEC disclosures. These are positions where Pershing owns more than 5% of a company:

Allergan AGN NaN% (AGN) – AGN represents 34% of his portfolio. He has a $6 billion stake in the company.

Air Products & Chemicals APD +0.72% (APD) – APD represents 17% of his portfolio. He has a $3.1 billion stake.

Canadian Pacific Rail (CP) – CP represents a 14% of his portfolio. He has a $2.6 billion stake.

Burger King Worldwide, Inc. (BKW) – BKW represents 8.5% of his portfolio. He has a stake worth $1.1 billion.

Platform Specialty Products Corp (PAH) – PAH represents 5% of his portfolio. He has a stake worth about $940 million.

The Howard Hughes Corporation (HHC) – HHC represents 3% of his portfolio. He has a stake of $510 million.

Zoetis Inc. (ZTS) – ZTS is a relatively new addition to his portfolio. According Pershing’s recent 13d filing, it has a stake representing about 10% of the Pershing portfolio, or a position valued at about $1.8 billion.

Ackman’s Pershing Square fund also holds small stakes in Fannie and Freddie Mac, as well as at least two undisclosed small positions. But Ackman has more than 75% of his fund’s money in just four stocks – long positions. That shows extraordinary conviction, and it also means he can’t afford to lose. That conviction and confidence is present only because he has the ability to gain control of, and influence on, the companies he invests in. helps average investors invest alongside Wall Street billionaires. By selecting the best ideas from the best billionaire investors and hedge funds, our exited stock investment recommendations have averaged a 31% gain since 2012.